NCT02935205 2023-11-29
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
University of California, Davis
Phase 1/2 Unknown
Clinical Trials
29 trialsNCT04097002 2023-10-31
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
Orca Therapeutics B.V.
Phase 1/2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT01197625 2022-09-27
Vaccine Therapy in Curative Resected Prostate Cancer Patients
Oslo University Hospital
Phase 1/2 Unknown
NCT05286840 2022-03-18
64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer
GU Research Network, LLC
Phase 1/2 Unknown
NCT02563691 2022-03-08
CROP
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT05156424 2021-12-14
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
Waterford Instituate of Technology
Phase 1/2 Unknown
NCT01505075 2020-11-24
pHART8
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT01953055 2020-11-24
SATURN
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT04429451 2020-06-12
PSMA-specific CAR-T Cell Therapy
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT02691975 2020-05-13
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Unknown
NCT03587285 2019-08-01
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 1/2 Unknown
NCT03516045 2018-05-17
A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer
Xiangya Hospital of Central South University
Phase 1/2 Unknown
NCT03525652 2018-05-16
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment
The First Affiliated Hospital of Guangdong Pharmaceutical University
Phase 1/2 Unknown
NCT02844699 2017-09-20
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Panacela Labs LLC
Phase 1/2 Unknown
NCT02452307 2017-08-17
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
University Hospital Tuebingen
Phase 1/2 Unknown
NCT03013712 2017-01-06
CARTEPC
First Affiliated Hospital of Chengdu Medical College
Phase 1/2 Unknown
NCT02721784 2016-10-26
SMART
University College, London
Phase 1/2 Unknown
NCT00126802 2016-07-06
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer
AHS Cancer Control Alberta
Phase 1/2 Unknown
NCT02816840 2016-06-29
PET-CT/MRI in the Radiotherapy for Prostate Cancer
Xuzhou Medical University
Phase 1/2 Unknown
NCT01436214 2015-07-16
Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
Adamis Pharmaceuticals Corporation
Phase 1/2 Unknown
NCT00002775 2014-01-06
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003183 2013-12-04
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT01225471 2011-06-23
Novel Peptide Vaccination for Patients With Advanced Prostate Cancer
Iwate Medical University
Phase 1/2 Unknown
NCT00895466 2009-05-08
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Pepscan Therapeutics
Phase 1/2 Unknown
NCT00122005 2009-02-24
GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
Providence Health & Services
Phase 1/2 Unknown
NCT00448734 2009-01-21
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Poniard Pharmaceuticals
Phase 1/2 Unknown
NCT00121095 2007-12-21
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Cytogen Corporation
Phase 1/2 Unknown
NCT00188383 2006-03-14
Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy
University Health Network, Toronto
Phase 1/2 Unknown